Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Cardiovascular and mortality benefits of sodium–glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia

Fig. 2

Forest plot of the adjusted incident hazard ratios (HR) and 95% CI for the different outcomes. CKD chronic kidney disease, CI confidence interval, HF heart failure, MACE major adverse cardiovascular events, HR hazard ratio, MI myocardial infarction, oGLDs other glucose-lowering drugs, PY patient-years of exposure, SGLT2i sodium–glucose co-transporter inhibitors

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840